Amway Malaysia Q3 Net Profit Falls 17.5% to RM12.1 Million as Revenue Slips 6.3% on Weak Consumer Demand
KUALA LUMPUR, Malaysia - November 16, 2026
Amway (Malaysia) Holdings Bhd, the publicly listed Malaysian arm of the Amway direct selling business, reported a drop in third-quarter profit on November 16 and warned that cautious consumer spending will keep weighing on its sales for the rest of 2026.
In its quarterly filing with Bursa Malaysia, the company said net profit for the three months ended September 30, 2026 fell to RM12.07 million, or 7.34 sen per share, from RM14.62 million, or 8.89 sen per share, in the same quarter of 2025, a decline of about 17.5 percent. Revenue for the quarter slipped 6.3 percent to RM258.28 million from RM275.55 million.
The company attributed most of the revenue decline to a tougher comparison. In September 2025 it launched a line of cellular health products, which lifted sales in the year-earlier quarter. It said lower sales volumes and higher selling and marketing expenses cut into profit, while product price adjustments partly offset those pressures.
The nine-month picture was also weaker. For the first nine months of 2026, net profit fell about 12.5 percent to RM26.49 million from RM30.27 million, and revenue declined 5.3 percent to RM792.07 million from RM836.54 million. Pre-tax profit for the period was down 8.7 percent at about RM36.3 million. The company blamed the year-to-date decline on continued softness in consumer demand.
Against the previous quarter, however, results improved. Third-quarter revenue was 4.9 percent lower than in the second quarter, but pre-tax profit rose 35.6 percent and net profit rose 38.7 percent quarter on quarter, which the company linked mainly to its price adjustments.
Looking ahead, Amway Malaysia said, "The cautious consumer environment is expected to continue weighing on the group's sales for the remainder of the year. However, as a result of prudent investments and product price adjustments, profitability is expected to stabilise." The company said it will keep its focus on health and wellbeing, emphasizing science-backed products that support healthy ageing, while adapting its business model to changing consumer preferences and making disciplined investments in sales capabilities, product innovation, and its digital and physical infrastructure.
Despite the lower earnings, the board declared a third interim dividend of five sen per share. The shares go ex-dividend on December 3, 2026, with payment scheduled for December 18, 2026.
More Amway news
Nine Direct Selling Companies Named to Happi 2025 Top 50 List
Nine direct selling companies made the 2025 Top 50 list of the largest U.S.-based household and personal products companies, ranked by sales. They are Amway at No. 13, Mary Kay at...
Amway Names Jon Voskuil Managing Director of ESAN as Region Sales Rise 5 Percent
Amway has named Jon L. Voskuil managing director of Amway ESAN, its Europe, Southern Africa, Australia and New Zealand region. The region's 2024 sales rose 5 percent to 424...
Amway Pledges 33 Million Dollars for Naming Rights to Grand Rapids Soccer Stadium
Amway has pledged 33 million dollars toward the design and construction of a professional soccer stadium in downtown Grand Rapids, Michigan, securing naming rights to the...
Amway Korea Names Shin Eun-ja CEO
Amway Korea has named its chief marketing officer, Shin Eun-ja, as its new chief executive, the company said October 21, 2024. Shin joined Amway Korea in 1995 and built her career...
Amway to Spend 4 Million Dollars on Four R and D Labs in India
Amway will spend 4 million dollars to build four research and development labs in India. The labs, totaling more than 24,000 square feet, will be located in Gurugram, Chennai...